Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial update for PHP-201 evaluating efficacy and safety in primary open angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt [Phase 1, Phase 2]
A phase 1/2 trial comparing generic brinzolamide to Azopt for glaucoma-related indications has completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: Post Market Study of the InnFocus MicroShunt [NA]
Post-market clinical trial update for the InnFocus MicroShunt in primary open-angle glaucoma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) Glaucoma Drainage Implant [NA]
Clinical trial update for the MIDI Arrow glaucoma drainage implant completed with posted results.
-
FDA approval · 2021-05-14FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Supplemental Application (Somerset Therapeutics, LLC)
FDA approves a supplemental application for the dorzolamide hydrochloride and timolol maleate combination eye drop, a generic product used t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-05-04FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals' original application for a generic dorzolamide hydrochloride and timolol maleate ophthalmic solution u…
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 [Phase 2]
Phase 2 clinical trial evaluating 24-hour intraocular pressure lowering and systemic exposure of PF-04217329 in glaucoma and ocular hyperten…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure. [Phase 2]
Phase 2 clinical trial updating safety and efficacy of PF-04217329 in patients with primary open-angle glaucoma or ocular hypertension; resu…
-
FDA approval · 2021-03-19FDA Approved: TRAVOPROST OPHTHALMIC — Original Application (Micro Labs Limited)
The FDA approved Micro Labs Limited's travoprost ophthalmic solution as an original application for reducing elevated intraocular pressure i…
-
FDA approval · 2021-03-16FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for the fixed-dose combination dorzolamide hydrochloride and timolol maleate from Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients [Phase 3]
Phase 3 trial evaluating latanoprost, timolol, and their combination for eye pressure reduction in open-angle glaucoma and ocular hypertensi…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma [Phase 3]
A Phase 3 randomized trial comparing evening dosing of Xalacom in glaucoma patients has completed, evaluating efficacy and safety in open-an…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma [Phase 4]
A Phase 4 randomized trial comparing evening dosing of Xalacom versus Cosopt in glaucoma patients completed.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications [NA]
A completed clinical trial of MINIject for open angle glaucoma uncontrolled by topical medications has posted results.
-
FDA approval · 2021-02-10FDA Approved: DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE — Supplemental Application (Indoco Remedies Limited)
FDA approved Indoco Remedies Limited's supplemental application for a generic dorzolamide hydrochloride and timolol maleate ophthalmic solut…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia [Phase 3]
Phase 3 trial update for open angle glaucoma or ocular hypertension conducted in Scandinavia; study completed.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom [Phase 3]
Phase 3 clinical trial in the United Kingdom evaluating treatment for open angle glaucoma or ocular hypertension; study status completed.
-
CLINICAL_TRIALS withdrawal · 2021-02-02Clinical Trial Update: Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device [Phase 3]
Phase 3 trial evaluating safety and efficacy of Xalatan delivered by a conventional dropper bottle versus a delivery device was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension [Phase 2]
A Phase 2 trial comparing latanoprost formulations to Xalatan for primary open-angle glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-31Clinical Trial Update: Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study [Phase 4]
Phase 4 clinical trial update evaluating peripapillary blood flow after use of anti-glaucoma medications using OCT angiography.
-
FDA approval · 2020-12-21FDA Approved: XELPROS — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for XELPROS (latanoprost) by Sun Pharmaceutical Industries, expanding the product’s labeling.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: 24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations [Phase 4]
Phase 4 trial update on fixed-combination dorzolamide/timolol and latanoprost/timolol for open-angle glaucoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: Tafluprost Preservative Free Switch Study [Phase 4]
Phase 4 trial update on a tafluprost preservative-free switch study for glaucoma patients.
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma [NA]
Clinical trial comparing 180-degree versus 360-degree selective laser trabeculoplasty as initial therapy for glaucoma has completed with res…
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: SYL040012, Treatment for Open Angle Glaucoma [Phase 2]
Phase 2 trial update for SYL040012 in open angle glaucoma and ocular hypertension has completed with results posted.